Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
2.49 Down 0.01(0.40%) Jul 29, 4:00PM EDT
Prev Close:2.50
Open:2.48
Bid:2.46 x 100
Ask:3.97 x 300
1y Target Est:10.17
Beta:0.72
Next Earnings Date:N/A
Day's Range:2.47 - 2.51
52wk Range:2.21 - 6.84
Volume:52,677
Avg Vol (3m):169,421
Market Cap:34.93M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RXII

Comparison

Symbol% ChgMkt Cap
RXIIDown 0.40%34.93M
AGNUp 0.44%50.86B
ALNYUp 3.79%4.18B
MRNADown 1.79%9.32M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):93.51
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.89
Quarterly EPS Est (Jun-14) :-0.25
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback